Study: SPECT sheds light on liver function, may aid cancer treatment

02/9/2013 | MedicalXpress.com

SPECT imaging with 99mTc-labeled iminodiacetic acid before and during radiation therapy to monitor hepatic function in patients with unresectable liver cancer provides data that could allow for more personalized treatment plans, according to a study presented at an imaging and radiation therapy conference. "The physiological adaptation of radiation therapy based upon individual response assessment is a valuable new paradigm worth additional testing," said lead researcher Hesheng Wang of the University of Michigan.

View Full Article in:

MedicalXpress.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations